Latest Growth Initiatives News

I Synergy Group Limited has successfully completed a $90,000 private placement by issuing 22.5 million shares at an 18.81% discount, aiming to bolster its growth and working capital.

Key Petroleum has submitted eight PCA applications in Queensland and launched a rights issue to raise A$312,225, aiming to fund both domestic development and international expansion despite a cash balance of just A$20,000 at quarter-end.

OncoSil Medical has reported a remarkable 233% increase in dose sales for Q3 FY25, alongside significant regulatory approvals and strategic expansions that position the company for accelerated growth.

Kaiser Reef Limited has announced a transformative acquisition of the Henty Gold Mine from Catalyst Metals, alongside a substantial capital raise and operational advancements, positioning the company for significant growth in gold production.

Bettr Entertainment Limited has launched a $130 million fully underwritten capital raising through a pro-rata entitlement offer and institutional placement, aiming to strengthen its financial position without materially affecting company control.

My Rewards International has completed its acquisition of Fly Wallet and strengthened its financial position with a $15 million put option facility, while working to lift its ASX trading suspension.

Careteq Limited reports strong Q3 FY25 progress with near completion of its 1-System platform integration, revenue growth exceeding forecasts, and new strategic partnerships broadening its healthcare footprint.

Austral Resources Australia Ltd reports key operational milestones including completion of Anthill West Pit mining and a strategic MOU with New Frontier Minerals, while progressing its recapitalisation and equity raise plans.

Uscom Limited reported a 14% rise in Q3 customer receipts to $0.73 million, even as cash reserves dropped 38% to $1.34 million, reflecting increased operating costs and global market pressures.

Vitasora Health Limited reports a striking 101% revenue increase and 57% patient growth in Q1 2025, driven by new Medicare Shared Savings Plan contracts and significant operational efficiencies from its Orb Health merger.

Nova Eye Medical reported a 27% rise in Q3FY25 sales excluding China, driven by record US performance and a sharp reduction in glaucoma segment losses. The company confirmed FY25 revenue guidance and unveiled plans to expand its iTrack™ technology into ocular drug delivery.

Pact Group Holdings reports a modest 2.7% revenue increase for Q3 FY25, driven by higher volumes and cost savings, while preparing to refinance debt and review its Asian packaging business.